| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
| VTP-194204 |
➤ Sign Up |
2,4-pentadienoic acid derivatives having retinoid-like biological activity |
Allergan Sales, Inc. (Irvine, CA) |
➤ Sign Up |
| VTP-194204 |
➤ Sign Up |
(1,2,3,4-tetrahydroquinolin-8-yl)-heptatrienoic acid derivatives having serum glucose reducing activity |
Allergan, Inc. (Irvine, CA) |
➤ Sign Up |
| VTP-194204 |
➤ Sign Up |
3,5-di-iso-propyl-heptatrienoic acid derivatives having serum glucose reducing activity |
Allergan, Inc. (Irvine, CA) |
➤ Sign Up |
| VTP-194204 |
➤ Sign Up |
5,6,7,8-tetrahydronaphthalen-2-yl 2,6-difluoroheptatrienoic acid derivatives having serum glucose reducing activity |
Allergan, Inc. (Irvine, CA) |
➤ Sign Up |
| VTP-194204 |
➤ Sign Up |
7-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity |
Allergan, Inc. (Irvine, CA) |
➤ Sign Up |
| VTP-194204 |
➤ Sign Up |
Compositions and methods for reducing serum glucose and triglyceride levels in diabetic mammals |
Allergan, Inc. (Irvine, CA) |
➤ Sign Up |
| VTP-194204 |
➤ Sign Up |
Treatment of cancer with specific RXR agonists |
Io Therapeutics, Inc. (Laguna Hills, CA) |
➤ Sign Up |
| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
